vs
Side-by-side financial comparison of Natera, Inc. (NTRA) and OCEANEERING INTERNATIONAL INC (OII). Click either name above to swap in a different company.
OCEANEERING INTERNATIONAL INC is the larger business by last-quarter revenue ($692.4M vs $665.5M, roughly 1.0× Natera, Inc.). Natera, Inc. runs the higher net margin — 7.1% vs 5.2%, a 1.9% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 2.7%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $-76.5M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 1.8%).
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...
Oceaneering International, Inc. is a subsea engineering and applied technology company based in Houston, Texas, U.S. that provides engineered services and hardware to customers who operate in marine, space, and other environments.
NTRA vs OII — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $665.5M | $692.4M |
| Net Profit | $47.3M | $36.1M |
| Gross Margin | — | — |
| Operating Margin | -3.4% | — |
| Net Margin | 7.1% | 5.2% |
| Revenue YoY | 39.8% | 2.7% |
| Net Profit YoY | 187.9% | -79.7% |
| EPS (diluted) | $0.36 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $692.4M | ||
| Q4 25 | $665.5M | $668.6M | ||
| Q3 25 | $592.2M | $742.9M | ||
| Q2 25 | $546.6M | $698.2M | ||
| Q1 25 | $501.8M | $674.5M | ||
| Q4 24 | $476.1M | $713.5M | ||
| Q3 24 | $439.8M | $679.8M | ||
| Q2 24 | $413.4M | $668.8M |
| Q1 26 | — | $36.1M | ||
| Q4 25 | $47.3M | $177.7M | ||
| Q3 25 | $-87.5M | $71.3M | ||
| Q2 25 | $-100.9M | $54.4M | ||
| Q1 25 | $-66.9M | $50.4M | ||
| Q4 24 | $-53.8M | $56.1M | ||
| Q3 24 | $-31.6M | $41.2M | ||
| Q2 24 | $-37.5M | $35.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 19.8% | ||
| Q3 25 | — | 20.6% | ||
| Q2 25 | — | 21.3% | ||
| Q1 25 | — | 20.0% | ||
| Q4 24 | — | 19.9% | ||
| Q3 24 | — | 19.3% | ||
| Q2 24 | — | 18.0% |
| Q1 26 | — | — | ||
| Q4 25 | -3.4% | 9.8% | ||
| Q3 25 | -16.5% | 11.6% | ||
| Q2 25 | -20.2% | 11.3% | ||
| Q1 25 | -15.8% | 10.9% | ||
| Q4 24 | -13.6% | 10.9% | ||
| Q3 24 | -8.9% | 10.5% | ||
| Q2 24 | -10.6% | 9.0% |
| Q1 26 | — | 5.2% | ||
| Q4 25 | 7.1% | 26.6% | ||
| Q3 25 | -14.8% | 9.6% | ||
| Q2 25 | -18.5% | 7.8% | ||
| Q1 25 | -13.3% | 7.5% | ||
| Q4 24 | -11.3% | 7.9% | ||
| Q3 24 | -7.2% | 6.1% | ||
| Q2 24 | -9.1% | 5.2% |
| Q1 26 | — | $0.36 | ||
| Q4 25 | $0.36 | $1.75 | ||
| Q3 25 | $-0.64 | $0.71 | ||
| Q2 25 | $-0.74 | $0.54 | ||
| Q1 25 | $-0.50 | $0.49 | ||
| Q4 24 | $-0.41 | $0.55 | ||
| Q3 24 | $-0.26 | $0.40 | ||
| Q2 24 | $-0.30 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | $488.8M |
| Stockholders' EquityBook value | $1.7B | $1.1B |
| Total Assets | $2.4B | $2.6B |
| Debt / EquityLower = less leverage | — | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $695.9M | ||
| Q3 25 | $1.0M | $7.0M | ||
| Q2 25 | $16.0M | $7.0M | ||
| Q1 25 | $17.8M | $7.0M | ||
| Q4 24 | $22.7M | $504.5M | ||
| Q3 24 | $29.5M | — | ||
| Q2 24 | $90.3M | — |
| Q1 26 | — | $488.8M | ||
| Q4 25 | — | $487.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $482.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $1.7B | $1.1B | ||
| Q3 25 | $1.3B | $907.7M | ||
| Q2 25 | $1.2B | $842.1M | ||
| Q1 25 | $1.2B | $773.1M | ||
| Q4 24 | $1.2B | $714.3M | ||
| Q3 24 | $878.5M | $698.0M | ||
| Q2 24 | $836.5M | $651.0M |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $2.4B | $2.7B | ||
| Q3 25 | $1.8B | $2.5B | ||
| Q2 25 | $1.8B | $2.3B | ||
| Q1 25 | $1.7B | $2.3B | ||
| Q4 24 | $1.7B | $2.3B | ||
| Q3 24 | $1.6B | $2.4B | ||
| Q2 24 | $1.5B | $2.3B |
| Q1 26 | — | 0.44× | ||
| Q4 25 | — | 0.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.67× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.9M | — |
| Free Cash FlowOCF − Capex | $37.8M | $-76.5M |
| FCF MarginFCF / Revenue | 5.7% | -11.1% |
| Capex IntensityCapex / Revenue | 5.4% | 2.5% |
| Cash ConversionOCF / Net Profit | 1.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | $109.1M | $238.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $73.9M | $221.1M | ||
| Q3 25 | $59.4M | $101.3M | ||
| Q2 25 | $37.6M | $77.2M | ||
| Q1 25 | $44.5M | $-80.7M | ||
| Q4 24 | $52.9M | $128.4M | ||
| Q3 24 | $51.8M | $91.9M | ||
| Q2 24 | $4.0M | $52.6M |
| Q1 26 | — | $-76.5M | ||
| Q4 25 | $37.8M | $190.7M | ||
| Q3 25 | $37.0M | $77.0M | ||
| Q2 25 | $11.7M | $46.9M | ||
| Q1 25 | $22.6M | $-106.8M | ||
| Q4 24 | $34.8M | $94.5M | ||
| Q3 24 | $35.5M | $67.0M | ||
| Q2 24 | $-7.7M | $29.8M |
| Q1 26 | — | -11.1% | ||
| Q4 25 | 5.7% | 28.5% | ||
| Q3 25 | 6.2% | 10.4% | ||
| Q2 25 | 2.1% | 6.7% | ||
| Q1 25 | 4.5% | -15.8% | ||
| Q4 24 | 7.3% | 13.2% | ||
| Q3 24 | 8.1% | 9.9% | ||
| Q2 24 | -1.9% | 4.5% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | 5.4% | 4.6% | ||
| Q3 25 | 3.8% | 3.3% | ||
| Q2 25 | 4.7% | 4.3% | ||
| Q1 25 | 4.3% | 3.9% | ||
| Q4 24 | 3.8% | 4.7% | ||
| Q3 24 | 3.7% | 3.7% | ||
| Q2 24 | 2.8% | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.56× | 1.24× | ||
| Q3 25 | — | 1.42× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | -1.60× | ||
| Q4 24 | — | 2.29× | ||
| Q3 24 | — | 2.23× | ||
| Q2 24 | — | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NTRA
Segment breakdown not available.
OII
| Backlog at end of period | $492.0M | 71% |
| Other | $162.8M | 24% |
| ROV days available | $22.5M | 3% |
| ROV days utilized | $15.1M | 2% |
